CoChat
Sign Up
Cited by 464Hormonal and reproductive studiesMuscle Physiology and DisordersMuscle metabolism and nutrition

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy

Sinha-Hikim, Indrani, Artaza, Jorge, Woodhouse, Linda, Gonzalez-Cadavid, Nestor, Singh, Atam B., Lee, Martin I., Storer, Thomas W., Casaburi, Richard, Shen, Ruoquing, Bhasin, Shalender·2002·American Journal of Physiology-Endocrinology and Metabolism
DOI 10.1152/ajpendo.00502.2001
Open this paper in CoChat — free account

Abstract

Administration of replacement doses of testosterone to healthy hypogonadal men and supraphysiological doses to eugonadal men increases muscle size. To determine whether testosterone-induced increase in muscle size is due to muscle fiber hypertrophy, 61 healthy men, 18–35 yr of age, received monthly injections of a long-acting gonadotropin-releasing hormone (GnRH) agonist to suppress endogenous testosterone secretion and weekly injections of 25, 50, 125, 300, or 600 mg testosterone enanthate (TE) for 20 wk. Thigh muscle volume was measured by magnetic resonance imaging (MRI) scan, and muscle biopsies were obtained from vastus lateralis muscle in 39 men before and after 20 wk of combined treatment with GnRH agonist and testosterone. Administration of GnRH agonist plus TE resulted in mean nadir testosterone concentrations of 234, 289, 695, 1,344, and 2,435 ng/dl at the 25-, 50-, 125-, 300-, and 600-mg doses, respectively. Graded doses of testosterone administration were associated with testosterone dose and concentration-dependent increase in muscle volume measured by MRI (changes in vastus lateralis volume, −4, +7, +15, +32, and +48 ml at 25-, 50-, 125-, 300-, and 600-mg doses, respectively). Changes in cross-sectional areas of both type I and II fibers were dependent on testosterone dose and significantly correlated with total ( r = 0.35, and 0.44, P < 0.0001 for type I and II fibers, respectively) and free ( r = 0.34 and 0.35, P < 0.005) testosterone concentrations during treatment. The men receiving 300 and 600 mg of TE weekly experienced significant increases from baseline in areas of type I (baseline vs. 20 wk, 3,176 ± 186 vs. 4,201 ± 252 μm 2, P < 0.05 at 300-mg dose, and 3,347 ± 253 vs. 4,984 ± 374 μm 2, P = 0.006 at 600-mg dose) muscle fibers; the men in the 600-mg group also had significant increments in cross-sectional area of type II (4,060 ± 401 vs. 5,526 ± 544 μm 2, P = 0.03) fibers. The relative proportions of type I and type II fibers did not change significantly after treatment in any group. The myonuclear number per fiber increased significantly in men receiving the 300- and 600-mg doses of TE and was significantly correlated with testosterone concentration and muscle fiber cross-sectional area. In conclusion, the increases in muscle volume in healthy eugonadal men treated with graded doses of testosterone are associated with concentration-dependent increases in cross-sectional areas of both type I and type II muscle fibers and myonuclear number. We conclude that the testosterone induced increase in muscle volume is due to muscle fiber hypertrophy.

Overview

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00502.2001

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 12

  1. Ayling CM, 1992, Growth Regul, 2, 133
  2. Bhasin S, 1998, J Clin Endocrinol Metab, 83, 3155
  3. Bhasin S, 1997, J Clin Endocrinol Metab, 82, 407
  4. Brodsky IG, 1996, J Clin Endocrinol Metab, 81, 3469
  5. Katznelson L, 1996, J Clin Endocrinol Metab, 81, 4358
  6. Mauras N, 1998, J Clin Endocrinol Metab, 83, 1886
  7. Scarpelli M, 1999, Anal Quant Cytol Histol, 21, 374
  8. Sinha-Hikim I, 1998, J Clin Endocrinol Metab, 83, 1312
  9. Snyder PJ, 2000, J Clin Endocrinol Metab, 85, 2670
  10. Tobin C, 1988, Biol Struct Morphog, 1, 28
  11. Wang C, 2000, J Clin Endocrinol Metab, 85, 2839
  12. Young NR, 1993, J Clin Endocrinol Metab, 77, 1028

Cited by

Sorted by citations

Items 301–400 of 464

Related

See all

Metadata

Authors
Sinha-Hikim, I., Artaza, J., Woodhouse, L., Gonzalez-Cadavid, N., Singh, A. B., Lee, M. I., Storer, T. W., Casaburi, R., Shen, R., & Bhasin, S.
Affiliations
  • Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, 90059; and
  • Charles R. Drew University of Medicine and Science (US)
  • University of California, Los Angeles (US)
ORCID
Venue
American Journal of Physiology-Endocrinology and Metabolism
Publisher
American Physiological Society
Published
2002-07-01
Volume
283
Issue
1
Pages
E154-E164
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
DOI
10.1152/ajpendo.00502.2001
OpenAlex
W2103672262
Cited by
464
References
47
Citations by year
2026: 14 · 2025: 20 · 2024: 21 · 2023: 16 · 2022: 30 · 2021: 22 · 2020: 20 · 2019: 18 · 2018: 20 · 2017: 21 · 2016: 17 · 2015: 14 · 2014: 20 · 2013: 28 · 2012: 17
FWCI
7.14
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5u01dk054047-06)
  • National Institute on Aging (1R01 AG-14369-01, R01AG014369)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1R01 DK 59627-01, U01-DK-54047, R01DK059627)
  • National Center for Research Resources (U54 RR-00425, G12RR003026, P20RR011145)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Keywords
testosterone enanthate, testosterone replacement therapy, muscle hypertrophy, muscle fiber cross-sectional area, vastus lateralis, thigh muscle volume, GnRH agonist, hypogonadism, dose-response relationship, free testosterone, healthy young men, muscle biopsy
MeSH terms
Adolescent, Adult, Body Composition, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Hypertrophy, Gonadotropin-Releasing Hormone, Magnetic Resonance Imaging, Male, Reference Values, Testosterone, Muscle, Skeletal, Muscle Fibers, Skeletal, Muscle Fibers, Fast-Twitch, Muscle Fibers, Slow-Twitch, Anatomy, Cross-Sectional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review